Two other explanations for the aforementioned phenomenon of TNF alpha inhibitors not reducing inflammatory effects on cardiac myocytes are 1) the polymorphism of the TNF alpha protein and 2) the TNF alpha inhibitors interaction with the pharmacodynamics of other drugs used for treatment of symptomatic HF, specifically between the TNF alpha inhibitors and medications employed for CHF [30]. Here, TNF is linked to congestive heart failure.